Literature DB >> 2982643

Cleavage of des-Arg9-bradykinin by angiotensin I-converting enzyme from pig kidney cortex.

G Oshima, Y Hiraga, K Shirono, S Oh-ishi, S Sakakibara, T Kinoshita.   

Abstract

Fast and very slow hydrolyses of des-Arg9-bradykinin and angiotensin II by angiotensin I-converting enzyme were detected by high performance liquid chromatography. The Michaelis constants of the enzyme, Km values, for des-Arg9-bradykinin and bradykinin were found to be 0.24 mM and 4.4 microM, and the maximum velocities, Vmax values (mumol . min-1 . mg protein-1) for these compounds to be 3.24 and 0.34, respectively. The enzyme also hydrolyzed Z-Gly-Pro-Gly-Gly-Pro-Ala to a tripeptide that was identified as dansyl-Gly-Pro-Ala by TLC on polyamide. These observations show that the enzyme hydrolyzes the peptides at the bond before the prolyl residue in the penultimate position.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982643     DOI: 10.1007/bf02004493

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  16 in total

1.  Dipeptidyl carboxypeptidase from Escherichia coli.

Authors:  A Yaron
Journal:  Methods Enzymol       Date:  1976       Impact factor: 1.600

2.  Angiotensin I-converting enzyme of the kidney cortex.

Authors:  G Oshima; A Gecse; E G Erdös
Journal:  Biochim Biophys Acta       Date:  1974-05-20

3.  Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung.

Authors:  D W Cushman; H S Cheung
Journal:  Biochem Pharmacol       Date:  1971-07       Impact factor: 5.858

4.  Stereospecificity of peptidyl dipeptide hydrolase (angiotensin I-converting enzyme).

Authors:  G Oshima; K Nagasawa
Journal:  J Biochem       Date:  1979-12       Impact factor: 3.387

5.  Renal angiotensin I-converting enzyme as a mixture of sialo- and asialo-enzyme, and a rapid purification method.

Authors:  G Oshima; K Nagasawa; J Kato
Journal:  J Biochem       Date:  1976-09       Impact factor: 3.387

6.  Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.

Authors:  M A Ondetti; B Rubin; D W Cushman
Journal:  Science       Date:  1977-04-22       Impact factor: 47.728

7.  Substrate binding properties of converting enzyme using a series of p-nitrophenylalanyl derivatives of angiotensin I.

Authors:  T H Massey; D C Fessler
Journal:  Biochemistry       Date:  1976-11-02       Impact factor: 3.162

8.  Tripeptidyl carboxypeptidase activity of kininase II (angiotensin-converting enzyme).

Authors:  J Inokuchi; A Nagamatsu
Journal:  Biochim Biophys Acta       Date:  1981-12-15

9.  Novel substrates for angiotensin I converting enzyme.

Authors:  L B Hersh; J T Gafford; J C Powers; T Tanaka; E G Erdös
Journal:  Biochem Biophys Res Commun       Date:  1983-01-27       Impact factor: 3.575

10.  The degradation of bradykinin (BK) and of des-Arg9-BK in plasma.

Authors:  F Marceau; M Gendreau; J Barabé; S St-Pierre; D Regoli
Journal:  Can J Physiol Pharmacol       Date:  1981-02       Impact factor: 2.273

View more
  1 in total

1.  Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema.

Authors:  R M Fryer; J Segreti; P N Banfor; D L Widomski; B J Backes; C W Lin; S J Ballaron; B F Cox; J M Trevillyan; G A Reinhart; T W von Geldern
Journal:  Br J Pharmacol       Date:  2007-12-17       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.